This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Contrino, J. Articles by Kreutzer, D. L. Search for Related Content PubMed PubMed Citation Articles by Contrino, J. Articles by Kreutzer, D. L.

American Journal of Pathology, Vol 145, 1315-1322, Copyright © 1994 by American Society for Investigative Pathology

REGULAR ARTICLES

In situ characterization of antigenic and functional tissue factor expression in human tumors utilizing monoclonal antibodies and recombinant factor VIIa as probes

J Contrino, GA Hair, MA Schmeizl, FR Rickles and DL Kreutzer
Department of Pathology, University of Connecticut Health Center, Farmington.

Tissue factor (TF), the primary initiator of blood coagulation in vivo, is expressed in vitro by a variety of cells. Previous efforts to localize TF in tissue and cells have been limited principally to the use of immunological techniques. In the present study, we describe a novel functional probe for TF expression, which can be utilized to localize functional TF in situ in human cells and tissues. This probe, a biotinylated phe-pro-arg-chloro-methyl-ketone-labeled rVIIa (FPR-ck- VIIa), interacts with TF via high-affinity binding sites. The binding of FPR-ck-VIIa, therefore, can be correlated with the ability of TF to activate clotting. In the described studies, TF antigen (TF:Ag) expression was examined immunohistochemically with various TF-specific monoclonal antibodies (MAbs) and was correlated with functional TF expression using our novel TF-binding probe (eg, FPR-ck-VIIa). Initial results indicate that TF:Ag expression correlates with the expression of functional TF (TF:VIIa), and the specificity of both types of probes was confirmed. Parallel antigenic and functional TF expression in situ was demonstrated in various human tumors. We believe this to be the first demonstration of functional TF in situ in human cells and tissues. We suggest that FPR-ck-VIIa should prove a useful reagent for studying the role of TF in the pathogenesis of clotting complications of human disease.

This article has been cited by other articles:

				C. Lupu, X. Hu, and F. Lupu Caveolin-1 Enhances Tissue Factor Pathway Inhibitor Exposure and Function on the Cell Surface J. Biol. Chem., June 10, 2005; 280(23): 22308 - 22317. [Abstract] [Full Text] [PDF]

				S. Butenas, B. A. Bouchard, K. E. Brummel-Ziedins, B. Parhami-Seren, and K. G. Mann Tissue factor activity in whole blood Blood, April 1, 2005; 105(7): 2764 - 2770. [Abstract] [Full Text] [PDF]

				J. Crawley, F. Lupu, A. D. Westmuckett, N. J. Severs, V. V. Kakkar, and C. Lupu Expression, Localization, and Activity of Tissue Factor Pathway Inhibitor in Normal and Atherosclerotic Human Vessels Arterioscler. Thromb. Vasc. Biol., May 1, 2000; 20(5): 1362 - 1373. [Abstract] [Full Text] [PDF]

				C. Lupu, E. Poulsen, S. Roquefeuil, A. D. Westmuckett, V. V. Kakkar, and F. Lupu Cellular Effects of Heparin on the Production and Release of Tissue Factor Pathway Inhibitor in Human Endothelial Cells in Culture Arterioscler. Thromb. Vasc. Biol., September 1, 1999; 19(9): 2251 - 2262. [Abstract] [Full Text] [PDF]

				C. Lupu, C. A. Goodwin, A. D. Westmuckett, J. J. Emeis, M. F. Scully, V. V. Kakkar, and F. Lupu Tissue Factor Pathway Inhibitor in Endothelial Cells Colocalizes With Glycolipid Microdomains/Caveolae : Regulatory Mechanism(s) of the Anticoagulant Properties of the Endothelium Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2964 - 2974. [Abstract] [Full Text]